All > Minnesota > Obesity

Phentermine Hydrochloride 8 MG for Obesity

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
Obesity+2 MorePhentermine Hydrochloride 8 MG - Drug
Eligibility
18 - 70
All Sexes
What conditions do you have?
Select

Study Summary

This trial is designed to study the long-term effects of the drug phentermine on weight, blood pressure, and other health outcomes.

Eligible Conditions
  • Obesity
  • Healthy Lifestyle

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Similar Trials

1
Phentermine/Topiramate (Qsymia)
2
Phentermine / Topiramate Oral Product
1
Meal Replacement Therapy

Study Objectives

0 Primary · 4 Secondary · Reporting Duration: Month 1, Month 2, Month 3, Month 6, Month 9, Month 12, Month 15, Month 18, Month 21, Month 24

Month 24
Change in cardiac autonomic function
Month 12
Change in body weight (%)
Month 18
Change in Systolic Blood Pressure (mmHg)
Month 24
Change in diet composition
Change in resting energy expenditure (REE) / resting metabolic rate (RMR)
Change in self-reported physical activity levels
Change in total daily energy intake (kcal/day)
Change in total daily steps
Month 24
Incident cardiovascular disease or death
Month 24
Dependence on study drug (phentermine)

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Similar Trials

1
Phentermine/Topiramate (Qsymia)
3
Phentermine / Topiramate Oral Product
2
Meal Replacement Therapy

Trial Design

2 Treatment Groups

Phentermine
1 of 2
Placebo
1 of 2

Experimental Treatment

Non-Treatment Group

1000 Total Participants · 2 Treatment Groups

Primary Treatment: Phentermine Hydrochloride 8 MG · Has Placebo Group · Phase 4

PhentermineExperimental Group · 2 Interventions: Online Lifestyle Behavioral Therapy, Phentermine Hydrochloride 8 MG · Intervention Types: Behavioral, Drug
Placebo
Behavioral
PlaceboComparator Group · 1 Intervention: Online Lifestyle Behavioral Therapy · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: month 1, month 2, month 3, month 6, month 9, month 12, month 15, month 18, month 21, month 24

Who is running the clinical trial?

Biomedical Research Institute of New MexicoOTHER
8 Previous Clinical Trials
1,193 Total Patients Enrolled
2 Trials studying Obesity
280 Patients Enrolled for Obesity
The University of Texas Health Science Center, HoustonOTHER
809 Previous Clinical Trials
255,185 Total Patients Enrolled
25 Trials studying Obesity
13,879 Patients Enrolled for Obesity
WW International Inc.UNKNOWN
3 Previous Clinical Trials
138 Total Patients Enrolled
1 Trials studying Obesity
Kaiser PermanenteOTHER
508 Previous Clinical Trials
22,254,348 Total Patients Enrolled
33 Trials studying Obesity
118,107 Patients Enrolled for Obesity
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,588 Previous Clinical Trials
46,944,999 Total Patients Enrolled
242 Trials studying Obesity
202,313 Patients Enrolled for Obesity
KVK-Tech, Inc.UNKNOWN
Wake Forest University Health SciencesLead Sponsor
1,122 Previous Clinical Trials
1,126,042 Total Patients Enrolled
35 Trials studying Obesity
4,314 Patients Enrolled for Obesity
Johns Hopkins UniversityOTHER
2,073 Previous Clinical Trials
31,016,225 Total Patients Enrolled
41 Trials studying Obesity
5,991 Patients Enrolled for Obesity
HealthPartners InstituteOTHER
167 Previous Clinical Trials
4,907,627 Total Patients Enrolled
9 Trials studying Obesity
43,681 Patients Enrolled for Obesity
Nicholas M Pajewski, PhDPrincipal InvestigatorWake Forest University Health Sciences
Kristina H Lewis, MDPrincipal InvestigatorWake Forest University Health Sciences
1 Previous Clinical Trials
120 Total Patients Enrolled
Jamy D Ard, MDPrincipal InvestigatorWake Forest University Health Sciences
5 Previous Clinical Trials
427 Total Patients Enrolled
3 Trials studying Obesity
192 Patients Enrolled for Obesity

Eligibility Criteria

Age 18 - 70 · All Participants · 8 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are interested in and willing to lose weight as a result of treatment.
You are able to take oral medication and willing to adhere to the clinical visit schedule for the trial and lifestyle based treatment regimen throughout the study duration, as recommended by the study clinician.
You are willing to comply with all study procedures and are available for the duration of the study.

Who else is applying?

What state do they live in?
Texas50.0%
North Carolina22.2%
California16.7%
Other11.1%
How old are they?
18 - 6593.3%
65+6.7%
What site did they apply to?
Kaiser Permanente Southern California25.0%
Atrium Health Wake Forest Baptist Weight Management Center25.0%
UT Center for Obesity Medicine and Metabolic Performance41.7%
Other8.3%
What portion of applicants met pre-screening criteria?
Met criteria73.7%
Did not meet criteria26.3%
How many prior treatments have patients received?
160.0%
220.0%
3+20.0%
Why did patients apply to this trial?
  • "i like to loose weight and keep it off"
  • "I’ve tried three drugs that are not working well as well as two tries of diets."
What questions have other patients asked about this trial?
  • "How long do screening visits take? Can I still do the study if I have tried phentermine?"

How responsive is this trial?

Typically responds via
Phone Call100.0%
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top